Mtg.cardsrealm
Login
Magic: the Gathering
Cards
Sets
Metagame
Tools
Articles
Decks
Tournament
Combos
Go Ad-Free
&
Name
Hand
1
2
3
4
5
6
7
8
-
0
Format:
Commander
Average mana cost:
Last change:
2023-09-07 21:20 UTC
Id of the deck:
251723
Recommendations:
Dina, Soul Steeper meta
Illegal cards
Tome of the Infinite
Schatteken
Pest Token
Insect Token
Fungus Beast Token
Copy Token
A-Haywire-mijt
A-Blood Artist
Please, confirm clicking more one time in the button
Be the first to comment
Moeras (97%)
Woud (96%)
Sol-ring (81%)
Commandotoren (80%)
Jungle Hol (80%)
Pristine Talisman (58%)
Sanguine Bond (55%)
Uitstekend bloed (53%)
Vito, Doorn van de Schemerroos (50%)
Zulaport Moordenaar (46%)
Witherbloom Campus (44%)
Sangromancer (40%)
Bojuka-moeras (40%)
Sakura-stamouderling (40%)
Llanowar Elfen (40%)
Tempel van Malady (40%)
De citadel van Bolas (40%)
Beledros Witherbloom (39%)
Grijze koopman van Asphodel (38%)
Sapseep Forest (38%)
Bron van verloren dromen (37%)
Hoge markt (34%)
Evoluerende wildernis (34%)
Revenge of Ravens (34%)
Duivelse docent (34%)
Stralende fontein (33%)
Bastion van Herinnering (33%)
Ooze opruimen (32%)
Falkenrath Noble (30%)
Overgrown Tomb (27%)
Essence Pulse (27%)
Eeuwige getuige (27%)
Keer terug naar de natuur (27%)
Bloeden (27%)
Pols van Murasa (27%)
Deadly Brew (25%)
Alhammarret's Archive (25%)
Schedelklem (25%)
Beest binnen (25%)
Vampiric Rites (25%)
Aetherflux Reservoir (25%)
Moordenaarstrofee (24%)
Retreat to Hagra (24%)
Blood Researcher (24%)
Ill-Gotten Inheritance (24%)
Talloos landschap (24%)
Riveteers Overlook (24%)
Wraakzuchtige vampier (24%)
Elfse mystiek (23%)
Golgari-zegel (23%)
Kazandu Nectarpot (23%)
Tablet van de Gilden (23%)
Blighted Woodland (23%)
Chain of Smog (22%)
Schemering Mire (22%)
Trespasser's Curse (22%)
Geschenk van het paradijs (22%)
Dorpsrituelen (22%)
Nature's Claim (20%)
Epicure van Bloed (20%)
Hardnekkige achtervolging (20%)
Courser of Kruphix (20%)
Dodelijke storm (19%)
Witch's Cottage (19%)
Jaddi Offshoot (19%)
07/09/23
12/06/24
06/01/26
17/10/23
14/01/26
26/12/25
Sign in and join the conversation
— Comments 0
, Reactions 1
Be the first to comment